跳至主要内容
临床试验/JPRN-UMIN000006028
JPRN-UMIN000006028尚未招募未知

A Study on the action mechanism of Ebastine for chronic urticaria and efficacy and safety in the long term follow-up trial - Trial of Ebastine for chronic urticaria

Department of Dermatology,Kinki University0 个研究点目标入组 20 人开始时间: 2011年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients complicated with a skin disorder blocking response evaluation 2) Patients who do not avoid continual use of drugs interrupting response evaluation (antiallergics, oral steroids, immunosuppressives) , except for patients who do not have a plan to change the of the drug dosage during the trial 3) Patients with severe complications including hepatic disease, renal disease, cardiac disease 4) Patients with pregnancy, its chance, and lactation 5) Patients receiving hyposensitization therapy 6) Patients taking antihistamines during 4 weeks before starting the trial 7) Patients whom doctors regarded inappropriate for the trial

研究者

发起方
Department of Dermatology,Kinki University

相似试验

A Study on the action mechanism of Ebastine for... | 临床试验